Systemic surfaceome profiling identifies target antigens for immune-based therapy in subtypes of advanced prostate cancer

Institutions FC
UCLA Department of Microbiology, Immunology and Molecular Genetics (MIMG), United States of America (USA) 0.23
UCLA Department of Biological Chemistry, United States of America (USA) 0.14
Duke Department of Pathology, United States of America (USA) 0.11
UCLA Department of Molecular and Medical Pharmacology (DMMP), United States of America (USA) 0.10
Stanford School of Medicine, United States of America (USA) 0.07
Yale School of Medicine (YSM), United States of America (USA) 0.07
Department of Urology, UW, United States of America (USA) 0.07
UCLA Jonsson Comprehensive Cancer Center (JCCC), United States of America (USA) 0.06
College of Basic Medical Science, CMU, China 0.04
UCLA Division of Hematology/Oncology, United States of America (USA) 0.02
UCLA Department of Urology, United States of America (USA) 0.02
UCLA Crump Institute for Molecular Imaging, United States of America (USA) 0.02
UCLA Metabolomics Center, United States of America (USA) 0.02
Parker Institute for Cancer Immunotherapy, United States of America (USA) 0.01
UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research (BSCRC), United States of America (USA) 0.01

Return